Marc A. Dall'Era, M.D.
Clinical Interests
Dr. Dall’Era specializes in the management of malignant disease of the urinary tract.
The specialty care Dr. Dall’Era offers includes:
• Multi-disciplinary and comprehensive care of patients with urologic malignancy
• Active surveillance for low risk prostate cancer
• Multi-parametric MRI/US fusion targeted prostate biopsy
• Blue Light Fluorescent cystoscopy for bladder cancer with Cysview
• Minimally invasive and robotic surgery of the kidney and prostate including prostatectomy,
partial nephrectomy, pyeloplasty/ureteral reconstruction
• Radical cystectomy and neobladder creation
• Advanced genomics testing of urologic cancers
Research/Academic Interests
Dr. Dall'Era's research interests include active surveillance for prostate cancer including utilization
of mp-MRI and biomarker discovery and validation. He is also involved in translational research for
urothelial cancer diagnosis and management including advanced genomics analysis of bladder
tumor.
Title
Specialty
Associate Professor and Vice Chair of Urology
Cancer, Urologic Oncology, Urology
Department
Urology
Division
Urology
Clinic
UC Davis Cancer Center
Center/Program Affiliation
Robotic Surgery Program
UC Davis Comprehensive Cancer Center
Address/Phone
Lawrence J. Ellison Ambulatory Care Center, 4860 Y St. Suite 2200 Sacramento, CA 95817
Phone: 916-734-2222
UC Davis Comprehensive Cancer Center, 2279 45th Street Sacramento, CA 95817
Phone: 916-734-5959
Marc A. Dall'Era, M.D.
Additional Phone
Education
Physician Referrals: 800-362-5566
M.D., UC Davis, Davis CA 2000
B.S., UC Davis, Davis CA 1995
Internships
General Surgery, University of Washington, Seattle WA 2000-2001
Residency
Urology, University of Washington, Seattle WA 2001-2005
Chief Resident, University of Washington, Seattle WA 2005-2006
Fellowships
Board Certifications
Professional Memberships
Oncology, UC San Francisco, San Francisco CA 2006-2008
American Board of Urology
American Urological Association
Society of Urologic Oncology
Western Section, American Urological Association
Select Recent Publications
To view a detailed list of Dr. Dall'Era's publications, please click here.
Dall’Era MA, Maddala T, Polychronopoulos L, Gallagher JR, Febbo PG, Denes BS. Utility of the
Oncotype DX Prostate Cancer Assay in Clinical Practice for Treatment Selection in Men Newly
Diagnosed with Prostate Cancer: A retrospective Chart Review Analysis. Urology Practice. 2015;
2,343-348.
Yuh L, Dall’Era MA, Penson DF, Evan CP. Active Surveillance for Prostate Cancer Under the Patient
Protection and Affordable Act. Urology Practice. 2015;2(4):154-159.
Pugashetti N, Yap SA, Lara PN, Gandour-Edwards R, Dall’Era MA. Metastatic signet-ring cell
carcinoma of the urinary bladder: A novel management approach to a rare tumour. Canadian
Urological Association Journal. 2015;9(3-4):E204-207.
Marc A. Dall'Era, M.D.
Belair CD, Paikari A, Moltzahn F, Shenoy A, Yau C, Dall’Era M, Simko J, Benz C, Blelloch R.
DGCR8 is Essential for Tumor Progression following PTEN loss in the prostate. EMBO. 2015;16
(9):1219-32.
Tomlinson B, Lin TY, Dall’Era M, Pan CX. Nanotechnology in Bladder Cancer: Current State of
Development and Clinical Practice. Nanomedicine (Lond). 2015;10(7):1189-1201.
Wu JN, Fish KM, Evans CP, Devere White RW, Dall'Era MA. No improvement noted in overall or
cause-specific survival for men presenting with metastatic prostate cancer over a 20-year period.
Cancer. 2014;120(6):818-23.
Dall'Era MA. The economics of active surveillance for prostate cancer. Curr Opin Urol. 2013;23(3):
278-82. Review.
Dall'Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, Freedland SJ, Klotz
LH, Parker C, Soloway MS. Active surveillance for prostate cancer: a systematic review of the
literature. Eur Urol. 2012;62(6):976-83. Review.
Keegan KA, Dall'Era MA, Durbin-Johnson B, Evans CP. Active surveillance for prostate cancer
compared with immediate treatment: an economic analysis. Cancer. 2012;118(14):3512-8.
Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg
L, Bailey DE Jr, Wallace ME, Kantoff PW, Carroll PR. Active surveillance for early-stage prostate
cancer: review of the current literature. Cancer. 2008;112(8):1650-9. Review.
© 2016 UC Regents